• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

Largest leucovorin-autism trial retracted

The Transmitter | R Drury
The Transmitter | R Drury

The four other studies that have looked at the use of folinic acid in autism have received many criticisms, including that they were not blinded properly and had small sample sizes, says Dorothy Bishop, emeritus professor of developmental neuropsychology at the University of Oxford. “The quality of the research is uniformly poor.”

Posted in: News on 02/07/2026 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2026 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice